Myeloma News and Research

RSS
Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

First cell-based gene therapy approved by the FDA for treating multiple myeloma

First cell-based gene therapy approved by the FDA for treating multiple myeloma

New blood test makes it easier to follow the progression of multiple myeloma

New blood test makes it easier to follow the progression of multiple myeloma

Bariatric surgery can reduce the risk of obesity-related cancers, study shows

Bariatric surgery can reduce the risk of obesity-related cancers, study shows

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

Underrepresentation in genomic databases may affect therapy selection for minority patients

Underrepresentation in genomic databases may affect therapy selection for minority patients

Novel cancer-fighting gene therapy enters phase I clinical trial

Novel cancer-fighting gene therapy enters phase I clinical trial

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

CAR T-cell therapy produces deep, sustained remissions in patients with relapsed myeloma

CAR T-cell therapy produces deep, sustained remissions in patients with relapsed myeloma

Benjamin L. Ebert receives Sjöberg Prize for breakthrough research on blood cancer

Benjamin L. Ebert receives Sjöberg Prize for breakthrough research on blood cancer

Immunomodulatory drugs improve the success rate of cancer therapies

Immunomodulatory drugs improve the success rate of cancer therapies

Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition

Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition

Study provides new insights into the mechanism of bone marrow tissue

Study provides new insights into the mechanism of bone marrow tissue

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

Two enzymes fuel transition from pre-cancer stem cells to leukemia stem cells

Two enzymes fuel transition from pre-cancer stem cells to leukemia stem cells

Whole body imaging detects more myeloma-defining disease, allows treatment to be initiated earlier

Whole body imaging detects more myeloma-defining disease, allows treatment to be initiated earlier

Designer DNA agent reduces myeloma stem cell abundance, lowers disease burden in mice

Designer DNA agent reduces myeloma stem cell abundance, lowers disease burden in mice

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

P2 COVID-19 study shows no material safety differences between opaganib and control arms

P2 COVID-19 study shows no material safety differences between opaganib and control arms